Literature DB >> 27769603

Long-term sensory disturbances after orbitozygomatic fractures.

Erik Neovius1, Maria Fransson2, Cecilia Persson3, Sophie Clarliden4, Filip Farnebo5, T Kalle Lundgren5.   

Abstract

BACKGROUND: Orbitozygomatic fractures often lead to infraorbital nerve (ION) injury, and affected sensibility is a common long-term complaint within this patient group. We present a long-term follow-up study where the validated von Frey filament system was used for testing ION sensibility. Furthermore, we examined the incidence of persistent nerve injury and whether more complex fractures led to more pronounced ION sensibility disturbances.
METHODS: Patients treated for facial fractures involving the orbitozygomatic complex were included and the follow-up time was 3 years or more. Depending on the location and severity of the fractures, the patients were divided into 4 groups. The patients answered a questionnaire before ION sensibility testing with von Frey filaments.
RESULTS: Eighty-one patients were examined: 65 males (80%) and 16 females (20%). Examinations were conducted between 3.0 and 7.6 years (mean 4.9 years) after injury. Sixteen patients (20%) had affected and 6 patients (7.4%) had severely affected ION sensibility according to von Frey testing. No statistically significant differences were found in terms of questionnaire score between the groups. There was also no statistically significant correlation between questionnaire results and log von Frey values. Although the effect of groups could not be statistically verified using the log von Frey values, a larger proportion of patients with complex fractures had higher log von Frey values than the other groups.
CONCLUSIONS: Patients with complex fractures report more permanent sensory disturbance of the ION after surgery than those with isolated orbitozygomatic fractures, although this could not be verified statistically with von Frey filament testing at several locations. Hence, a validated method for testing facial sensibility such as von Frey filaments, although sensitive, is inadequate to determine all aspects of sensory malfunction after orbitozygomatic fractures. This suggests that the patient's experience of long-term sensation after trauma may not be correlated with objective measures.
Copyright © 2016 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Infraorbital nerve; Long-term follow-up; Orbitozygomatic fractures; Sensibility; von Frey filament

Mesh:

Year:  2016        PMID: 27769603     DOI: 10.1016/j.bjps.2016.09.007

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  5 in total

1.  Incidence, Aetiology, and Associated Fracture Patterns of Infraorbital Nerve Injuries Following Zygomaticomaxillary Complex Fractures: A Retrospective Analysis of 272 Patients.

Authors:  Kathia Dubron; Maarten Verbist; Eman Shaheen; Titiaan Jacob Dormaar; Reinhilde Jacobs; Constantinus Politis
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2021-06-17

2.  Does the Lag Time Between Injury and Treatment Affect Recovery of Infraorbital Nerve Disturbances in Zygomaticomaxillary Complex Fractures?

Authors:  Reza Tabrizi; Majid Neamati; Sara Rajabloo; Fatemeh Latifi
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-03-17

3.  Blink reflex changes and sensory perception in infraorbital nerve-innervated areas following zygomaticomaxillary complex fractures.

Authors:  Young Sook Park; Jaehoon Choi; Sang Woo Park
Journal:  Arch Plast Surg       Date:  2020-11-15

4.  Treatment of Zygomatic Complex Fractures with Surgical or Nonsurgical Intervention: A Retrospective Study.

Authors:  Thomas Starch-Jensen; Linda Busk Linnebjerg; Janek Dalsgaard Jensen
Journal:  Open Dent J       Date:  2018-05-21

5.  Patient-Reported Symptoms after Midfacial Trauma.

Authors:  Nina Pauli; Martina Grinups; Lena Folkestad; Gunnhildur Gudnadottir
Journal:  Surg J (N Y)       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.